)
Visual24 Oct 2025
The rise of Alphabet
Cardiol Therapeutics (CRDL) investor relations material
Cardiol Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
Focused on developing anti-inflammatory and anti-fibrotic therapies for heart disease, with lead candidate CardiolRx™ in advanced clinical trials for recurrent pericarditis and acute myocarditis.
Phase II MAVERIC-Pilot and ARCHER trials showed CardiolRx™ was well tolerated and demonstrated clinical proof of concept, supporting further development.
Enrolled first patient in Phase III MAVERIC trial for recurrent pericarditis in April 2025; topline ARCHER results announced in August 2025.
Cash and cash equivalents of $18.2M at June 30, 2025, expected to fund operations into Q3 2026.
Financial highlights
Net loss for Q2 2025 was $8.4M, up from $6.6M in Q2 2024; six-month net loss was $16.6M, up from $15.8M year-over-year.
No revenue generated; operating expenses driven by R&D ($2.7M in Q2, $6.5M YTD) and G&A ($4.9M in Q2, $9.6M YTD).
Interest income for Q2 was $181K, down from $307K in Q2 2024.
Cash used in operations for the first half of 2025 was $11.7M.
Outlook and guidance
Anticipates completion of Phase III MAVERIC enrollment in H1 2026 and advancement of CRD-38 development.
Current cash position expected to fund operations and milestones into Q3 2026.
May seek pharmaceutical partners for commercialization and further clinical development.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cardiol Therapeutics earnings date
Q3 202512 Nov, 2025
Next Cardiol Therapeutics earnings date
Q3 202512 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cardiol Therapeutics Inc. is a biopharmaceutical company focused on developing anti-inflammatory and anti-fibrotic therapies for cardiovascular diseases. The company specializes in small molecule therapeutics targeting conditions such as acute myocarditis, heart failure, and other inflammatory heart disorders. The company is headquartered in Oakville, Ontario, Canada, and its shares are listed on the NASDAQ and TSX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage